ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,386Medicare Part D Prescriptions Filled, Including Refills

Rank: 108 out of 2456

$754K Total Retail Price of All Prescriptions

Rank: 87 out of 2456

254 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 254 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 12,316 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

49 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
LEVOTHYROXINE SODIUM 649 649 1 4
FUROSEMIDE 614 614 2 8
SIMVASTATIN 466 457 3 2
DONEPEZIL HCL 415 415 4 23
LISINOPRIL 389 379 5 1
CITALOPRAM HBR 345 345 6 14
OMEPRAZOLE 327 318 7 3
NAMENDA 297 297 8 42
METOPROLOL TARTRATE 285 278 9 10
TRAZODONE HCL 226 225 10 17
POTASSIUM CHLORIDE 214 214 11 33
WARFARIN SODIUM 194 194 12 9
AMLODIPINE BESYLATE 194 194 12 5
SERTRALINE HCL 179 177 14 21
LIDODERM 177 176 15 58
QUETIAPINE FUMARATE 171 171 16 47
RISPERIDONE 168 168 17 50
ATORVASTATIN CALCIUM 164 164 18 12
GABAPENTIN 159 159 19 16
MIRTAZAPINE 157 157 20 29
OLANZAPINE 156 156 21 57
IPRATROPIUM-ALBUTEROL 144 144 22 85
TRAMADOL HCL 144 144 22 24
ATENOLOL 142 142 24 6
DIVALPROEX SODIUM 140 140 25 51
LANTUS 138 138 26 44
LEVOFLOXACIN 132 132 27 103
GLIPIZIDE 130 130 28 46
PREDNISONE 129 129 29 39
DIOVAN 123 122 30 26
ISOSORBIDE MONONITRATE ER 119 119 31 48
CARBIDOPA-LEVODOPA 116 116 32 82
CYMBALTA 113 113 33 65
ADVAIR DISKUS 105 105 34 36
NOVOLOG 103 103 35 100
ENABLEX 101 101 36 361
TAMSULOSIN HCL 96 94 37 32
METOPROLOL SUCCINATE 91 91 38 13
METFORMIN HCL 88 88 39 11
SEROQUEL 74 74 40 102
EXELON 74 74 40 161
DILTIAZEM 24HR CD 74 74 40 113
DIGOXIN 73 73 43 49
FINASTERIDE 71 71 44 66
SPIRIVA 67 67 45 43
NYSTOP 66 66 46 125
VESICARE 65 65 47 205
ALLOPURINOL 64 64 48 27
BACLOFEN 62 60 49 112
FLUOXETINE HCL 62 62 49 45
COLCRYS 61 60 51 171
LATANOPROST 61 61 51 156
ALENDRONATE SODIUM 60 60 53 19
CARVEDILOL 58 58 54 54
FLUTICASONE PROPIONATE 57 55 55 30
AZITHROMYCIN 57 55 55 60
BETAMETHASONE DIPROPIONATE 54 54 57 233
ESTRING 53 53 58 478
HYDROCHLOROTHIAZIDE 53 47 58 7
METHENAMINE HIPPURATE 52 52 60 237
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 25, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.